Press Releases

All Releases
View Summary Myriad Genetics to Announce Financial Results for the Fiscal Fourth Quarter and Full Year 2014 on August 12, 2014
Jul 30, 2014
PDF 11.6 KB Add to Briefcase
View Summary Crescendo Bioscience to Present Multiple Studies at 2014 EULAR Meeting
Jun 10, 2014
PDF 23.3 KB Add to Briefcase
View Summary Myriad Announces Retirement of James Evans, Chief Financial Officer
Jun 9, 2014
PDF 14.3 KB Add to Briefcase
View Summary Myriad Genetics to Present at the Goldman Sachs Global Healthcare Conference
Jun 3, 2014
PDF 11.0 KB Add to Briefcase
View Summary Myriad Genetics Announces Participation in Innovative Collaboration to Accelerate Hereditary Cancer Research
Jun 2, 2014
PDF 26.9 KB Add to Briefcase
View Summary Myriad myPath Melanoma Test Improves the Reliability of Melanoma Diagnosis
Jun 2, 2014
PDF 17.2 KB Add to Briefcase
View Summary Myriad Presents Clinical Data on Myriad myRisk Hereditary Cancer Test at ASCO
Jun 2, 2014
PDF 16.5 KB Add to Briefcase
View Summary Myriad Presents Data on BRACAnalysis CDx and HRD at 2014 ASCO Meeting
May 30, 2014
PDF 19.1 KB Add to Briefcase
View Summary Prolaris® Test Predicts Mortality Risk in Prostate Cancer Biopsy Study
May 20, 2014
PDF 17.8 KB Add to Briefcase
View Summary Myriad Strengthens Commitment to Cancer Research at the ASCO 50th Annual Meeting
May 15, 2014
PDF 18.2 KB Add to Briefcase
View Summary Crescendo Bioscience's Vectra® DA Predicts Radiographic Progression in Patients With Early Rheumatoid Arthritis
May 14, 2014
PDF 39.3 KB Add to Briefcase
View Summary Myriad Genetics to Present at the Bank of America 2014 Healthcare Conference
May 9, 2014
PDF 22.4 KB Add to Briefcase
View Summary Myriad Genetics Reports Financial Results for Third Quarter of Fiscal Year 2014
May 6, 2014
PDF 36.2 KB Add to Briefcase
View Summary Myriad and UnitedHealthcare Sign Three-Year Agreement Making myRisk Hereditary Cancer Test Available to United Members
May 6, 2014
PDF 13.9 KB Add to Briefcase
View Summary Myriad Genetics to Present Three Clinical Studies on Prolaris® at the 2014 American Urological Association Annual Meeting
May 1, 2014
PDF 16.7 KB Add to Briefcase
View Summary Myriad Genetics to Announce Financial Results for the Third Quarter of Fiscal Year 2014 on Tuesday, May 6, 2014
Apr 22, 2014
PDF 23.3 KB Add to Briefcase
View Summary Myriad Genetics Submits Premarket Approval to FDA for BRACAnalysis®
Apr 7, 2014
PDF 14.8 KB Add to Briefcase
View Summary Myriad to Present Seven Clinical Studies at the Annual Clinical Genetics Meeting
Mar 25, 2014
PDF 27.6 KB Add to Briefcase
View Summary Myriad Announces HRD Companion Diagnostic Collaboration With Tesaro
Mar 24, 2014
PDF 26.0 KB Add to Briefcase
View Summary Institut Pasteur and Myriad RBM Publish Initial Results From Landmark Study of Immune Response
Mar 20, 2014
PDF 72.5 KB Add to Briefcase
Showing 1-20 of 308 Page: 1 2 3 4 5 ... 16  Next 20
Add to Briefcase = add release to Briefcase

Stock Quote (NASDAQ:MYGN)

Price:
37.12
Change:
+ 1.02
Open:
35.94
Previous Close:
36.10
Day High:
37.70
Day Low:
35.80
52 Week High:
42.50
52 Week Low:
20.02
Volume:
664,400
4:00 PM ET on Aug 1, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Investor Contact

Scott Gleason
(801) 584-1143
sgleason@myriad.com

Media Contact

Ron Rogers
Corporate Communications and Media Relations
(801) 584-3065
rrogers@myriad.com